Patents by Inventor Yasuji Furutani

Yasuji Furutani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of microbial infection with interleukin 1 polypeptides
    Patent number: 5494663
    Abstract: DNAs encoding polypeptides having interleukin 1, vectors inserted with said DNAs, hosts transformed with said recombinant vectors, polypeptides having interleukin 1 activity which are produced by cultivation of the transformed hosts, derivatives of the polypeptides, pharmaceutical composition containing said polypeptides or derivatives, their use as an antitumor or antiinfectious agent, and processes for the preparation thereof.
    Type: Grant
    Filed: June 2, 1994
    Date of Patent: February 27, 1996
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Masaaki Yamada, Yasuji Furutani, Michiko Yamayoshi, Mitsue Notake, Junichi Yamagishi
  • Treatment of sarcoma with interleukin 1.alpha. polypeptides
    Patent number: 5376639
    Abstract: DNAs encoding polypeptides having interleukin 1, vectors inserted with said DNAs, hosts transformed with said recombinant vectors, polypeptides having interleukin 1 activity which are produced by cultivation of the transformed hosts, derivatives of the polypeptides, pharmaceutical composition containing said polypeptides or derivatives, their use as an antitumor or antiinfectious agent, and processes for the preparation thereof.
    Type: Grant
    Filed: September 30, 1992
    Date of Patent: December 27, 1994
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Masaaki Yamada, Yasuji Furutani, Michiko Yamayoshi, Mitsue Notake, Junichi Yamagishi
  • Human tumor necrosis factor polypeptides
    Patent number: 5288852
    Abstract: A novel cloned DNA encoding a human tumor necrosis factor (TNF), a vector having said DNA inserted thereinto, a host transformed with said vector and a novel human TNF polypeptide, and processes for producing them.
    Type: Grant
    Filed: July 1, 1993
    Date of Patent: February 22, 1994
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Masaaki Yamada, Yasuji Furutani, Mitsue Notake, Juniti Yamagishi
  • DNA encoding rabbit TNE, vector having said DNA inserted thereinto, host transformed with said vector, rabbit TNF polypeptide, and process for production thereof
    Patent number: 5043271
    Abstract: A novel cloned DNA encoding a rabbit Tumor Necrosis Factor (TNF) or a principal portion thereof, a vector having said DNA inserted thereinto, a host transformed with said vector, a novel polypeptide having or containing the rabbit TNF or a principal portion thereof, and a process for producing said polypeptide comprising cultivating said transformed host.
    Type: Grant
    Filed: November 30, 1984
    Date of Patent: August 27, 1991
    Assignee: Dainippon Pharmaceutical Co., Ltd.
    Inventors: Masaaki Yamada, Yasuji Furutani, Nitsue Notake